Phase IIb Study of F-1311 in Patients with Prostate Cancer

Trial Profile

Phase IIb Study of F-1311 in Patients with Prostate Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs Technetium tc 99m trofolastat (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Adverse reactions; Diagnostic use
  • Sponsors FUJIFILM RI Pharma
  • Most Recent Events

    • 11 Jul 2017 Status changed from recruiting to completed.
    • 09 Nov 2016 Planned End Date changed from 31 Oct 2016 to 31 Mar 2017.
    • 10 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top